Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
$6.60
+0.9%
$7.76
$6.12
$9.15
$355.54M1.0876,157 shs18,816 shs
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
$19.69
-0.3%
$21.24
$12.22
$23.75
$1.46B1.4115,520 shs2,178 shs
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
$6.14
-1.4%
$6.36
$5.36
$8.28
$446.99M1.55298,289 shs79,601 shs
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
$2.10
-4.5%
$2.31
$1.73
$3.79
$394.95M1.6410.83 million shs33.91 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
+0.93%-7.89%-15.94%-15.72%-5.49%
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
+0.46%+2.60%-11.16%-6.62%+5.95%
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
+1.63%-1.58%-0.48%-6.88%+13.07%
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
0.00%0.00%0.00%0.00%-29.05%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
3.8384 of 5 stars
3.04.00.00.02.62.53.1
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
4.4682 of 5 stars
3.53.02.50.02.51.73.8
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
3.2653 of 5 stars
3.53.00.00.00.03.32.5
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
0.4929 of 5 stars
2.00.00.00.00.02.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
2.00
Hold$8.5028.79% Upside
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
3.00
Buy$29.6750.67% Upside
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
3.00
Buy$9.7057.98% Upside
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
2.00
Hold$2.4315.87% Upside

Current Analyst Ratings

Latest BBCP, BBU, CTLP, and SLGC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/25/2024
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
2/23/2024
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00
2/14/2024
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$10.00
2/5/2024
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform$33.00 ➝ $34.00
2/5/2024
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$31.00 ➝ $32.00
2/5/2024
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$26.50 ➝ $28.00
1/26/2024
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$29.00 ➝ $31.00
1/24/2024
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$28.00 ➝ $30.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
$442.24M0.80$1.59 per share4.15$5.63 per share1.17
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
$55.07B0.03$98.45 per share0.20$239.52 per share0.08
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
$243.64M1.83$0.13 per share46.46$2.27 per share2.70
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
$97.67M4.04N/AN/A$3.00 per share0.70

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
$31.79M$0.3518.8611.00N/A4.81%7.76%2.61%6/13/2024 (Estimated)
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
$482M$6.493.034.33N/A6.86%21.74%4.30%5/3/2024 (Confirmed)
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
$630K$0.1932.3222.74N/A5.90%8.95%5.07%5/9/2024 (Confirmed)
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
-$109.16M-$0.69N/AN/AN/A-159.54%-24.72%-21.62%N/A

Latest BBCP, BBU, CTLP, and SLGC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
$0.05N/A-$0.05N/AN/AN/A
5/3/2024N/A
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
$0.86N/A-$0.86N/AN/AN/A  
3/7/2024Q1 2024
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
$0.03-$0.02-$0.05$0.04$98.25 million$97.71 million
2/8/2024Q2 2024
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
$0.02$0.04+$0.02$0.04$66.92 million$65.36 million
2/2/202412/31/2023
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
$0.90$6.57+$5.67$6.57N/A$13.41 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
N/AN/AN/AN/AN/A
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
$0.251.27%N/A3.85%N/A
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
N/AN/AN/AN/AN/A

Latest BBCP, BBU, CTLP, and SLGC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/2/2024
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
quarterly$0.06251.1%2/28/20242/29/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
1.21
1.10
1.01
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
2.22
1.04
0.78
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
0.21
1.64
1.20
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
N/A
17.79
17.29

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
34.20%
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
85.04%
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
75.75%
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
66.35%

Insider Ownership

CompanyInsider Ownership
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
27.40%
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
N/A
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
4.30%
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
14.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Concrete Pumping Holdings, Inc. stock logo
BBCP
Concrete Pumping
1,72053.87 million39.11 millionOptionable
Brookfield Business Partners L.P. stock logo
BBU
Brookfield Business Partners
72,00074.28 millionN/AOptionable
Cantaloupe, Inc. stock logo
CTLP
Cantaloupe
28072.80 million69.67 millionOptionable
Standard BioTools Inc. stock logo
SLGC
Standard BioTools
451188.07 million160.05 millionOptionable

BBCP, BBU, CTLP, and SLGC Headlines

SourceHeadline
Standard BioTools Inc LABStandard BioTools Inc LAB
morningstar.com - April 18 at 10:25 PM
LAB May 2024 2.500 callLAB May 2024 2.500 call
finance.yahoo.com - February 25 at 10:47 PM
Standard BioTools Inc.: Standard BioTools Stockholders Approve Merger with SomaLogicStandard BioTools Inc.: Standard BioTools Stockholders Approve Merger with SomaLogic
finanznachrichten.de - January 5 at 8:05 AM
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special MeetingMadryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting
finance.yahoo.com - January 4 at 8:10 PM
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioToolsMadryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
finance.yahoo.com - January 4 at 3:10 PM
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioToolsProxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
finance.yahoo.com - January 3 at 8:41 AM
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioToolsSomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools
finance.yahoo.com - January 2 at 9:39 AM
Boston Millennia Partners To Vote Against Proposed Merger Of SomaLogic With Standard BioToolsBoston Millennia Partners To Vote Against Proposed Merger Of SomaLogic With Standard BioTools
markets.businessinsider.com - January 1 at 8:18 AM
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioToolsLeading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioTools
finance.yahoo.com - December 29 at 7:20 PM
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional DisclosuresMadryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
finance.yahoo.com - December 29 at 7:20 PM
SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All StockholdersSomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders
finance.yahoo.com - December 29 at 9:18 AM
SomaLogic founder, CTO urge shareholders to vote against mergerSomaLogic founder, CTO urge shareholders to vote against merger
msn.com - December 28 at 7:15 PM
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogics Proposed Merger with Standard BioToolsDr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
finance.yahoo.com - December 28 at 7:15 PM
SomaLogic Issues Statement Correcting Madryn Asset Managements Misleading DisclosureSomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
finance.yahoo.com - December 26 at 6:51 PM
Another investor opposes Somalogic mergerAnother investor opposes Somalogic merger
bizwest.com - December 26 at 1:50 PM
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of AlternativesMadryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
finance.yahoo.com - December 26 at 1:50 PM
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsMadryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
businesswire.com - December 24 at 6:07 PM
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw "Cautionary Support" for SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsMadryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw "Cautionary Support" for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
finance.yahoo.com - December 24 at 1:07 PM
Tikvah Management Announces Intention to Vote against Somalogic’s Proposed Merger with Standard BioToolsTikvah Management Announces Intention to Vote against Somalogic’s Proposed Merger with Standard BioTools
finance.yahoo.com - December 22 at 8:41 PM
Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioToolsMadryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
finance.yahoo.com - December 22 at 8:41 PM
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioToolsMadryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
finance.yahoo.com - December 22 at 9:48 AM
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor PresentationMadryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation
finance.yahoo.com - December 21 at 8:51 AM
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioToolsSomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
finance.yahoo.com - December 21 at 8:51 AM
MERGER INVESTIGATION: Kaskela Law LLC Announces Investigation of SomaLogic, Inc. (NASDAQ: SLGC)MERGER INVESTIGATION: Kaskela Law LLC Announces Investigation of SomaLogic, Inc. (NASDAQ: SLGC)
bakersfield.com - December 20 at 11:55 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Concrete Pumping logo

Concrete Pumping

NASDAQ:BBCP
Concrete Pumping Holdings, Inc. provides concrete pumping and waste management services in the United States and the United Kingdom. The company offers concrete pumping services to general contractors and concrete finishing companies in the commercial, infrastructure, and residential sectors under the Brundage-Bone and Capital Pumping brands; and industrial cleanup and containment services primarily to customers in the construction industry under the Eco-Pan brand. It leases and rents concrete pumping equipment, pans, and containers. As of October 31, 2023, the company owned a fleet of approximately 930 boom pumps, 90 placing booms, 20 telebelts, 300 stationary pumps, and 115 waste management trucks. Concrete Pumping Holdings, Inc. was founded in 1983 and is headquartered in Thornton, Colorado.
Brookfield Business Partners logo

Brookfield Business Partners

NYSE:BBU
Brookfield Business Partners L.P. is a private equity firm specializing in acquisition. The firm typically invests in business services, infrastructure services, construction, energy, and industrials sector. It prefers to take majority stake in companies. The firm seeks returns of at least 15% on its investments. Brookfield Business Partners L.P. was founded in 2016 and is based in Hamilton, Bermuda. Brookfield Business Partners L.P. operates as a subsidiary of Brookfield Corporation.
Cantaloupe logo

Cantaloupe

NASDAQ:CTLP
Cantaloupe, Inc., a digital payments and software services company, provides technology solutions for the unattended retail market. The company offers integrated solutions for payments processing, logistics, and back-office management. It also provides ePort, an integrated payment device that is deployed in self-service, unattended market applications, such as vending, micro-markets, amusement, arcade, commercial laundry, air/vacuum, car wash, and others, which facilitates digital payments; and integrated software services for payment or asset tracking devices. In addition, the company offers G11 cashless kit, a 4G LTE digital payment device or payment and consumer engagement applications; G11 chip kit, a digital reader that accepts contact EMV (chip cards) and contactless EMV (tap) payment methods; Engage series comprising Engage and Engage Combo, which are digital touchscreen devices that provides networking, security, and interactivity payment methods. Further, it provides self-checkout kiosks,?smart store?concepts, and the Cantaloupe Go management platform comprising Go Mini, Go MiniX, Go Plus 100, Go Plus 200, Go Plus 300, Go Max, Cooler Café, Smart Market, and Go Portal, a robust cloud-based platform, as well as Go consumer mobile app, loyalty programs, campus card integrations, digital ad-management, and data warehouse services. The company was formerly known as USA Technologies, Inc and changed its name to Cantaloupe, Inc. Cantaloupe, Inc. was incorporated in 1992 and is headquartered in Malvern, Pennsylvania.
Standard BioTools logo

Standard BioTools

NASDAQ:SLGC
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.